St. Jude's next-gen heart defibrillators gain CE mark

05/10/2013 | RTT News

St. Jude Medical has earned the CE mark in Europe to market its Ellipse and SJM Assura implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The devices automatically adjust voltage in the event of an electrical short and help reduce risk for lead abrasion.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY